While the fate of the use of mifepristone for abortions remains uncertain, experts said, use of the drug misoprostol by itself is effective and safe, but not ideal.
The procedure is most likely to cause significant pain in women with a high baseline level of anxiety and those with dysmenorrhea within the previous year.
Two studies report few complications from continuing ocrelizumab and natalizumab into pregnancy, with high live birth rates, a decline in elective abortions, and few major congenital abnormalities in newborns.